Loading
Latest filing published 09 Jan 2017 for Kalytera Therapeutics, Inc..
No signal scores available.
David Stefansky discloses dealings in Kalytera Therapeutics, Inc. to SEDI. Activity is concentrated on a single trading day, 30 December 2016, with 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 9 January 2017, the filings show a transaction in Kalytera Therapeutics, Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations